Announcement
Anthropic's Claude AI shows early drug-development results across six partnerships
Anthropic says Claude generated roughly 35,000 antibody designs in about a month for Divergence Labs' food-allergy research.
TLDR
Anthropic says it partnered with six organizations developing medicines and began its own programs for rare childhood muscular dystrophy. For food-allergy research, it reports that Claude generated roughly 35,000 antibody designs in about a month; early lab tests identified promising components. In separate work, one Claude-assisted CAR T-cell therapy component was about 70% shorter than the standard version, while Enveda's Claude-based system reduced human manufacturing-record review time by 89% in one evaluation. Anthropic says most of the research remains preclinical.
Combined views
652.7K
7 Sources, first seen ago
